SCHEMBL185845

SCHEMBL185845

COc1ccc(CCl)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.68
TTR P02766 2/20 0.68
ATM Q13315 2/20 0.59
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 2/20 0.57
PPARG P37231 1/20 0.57
PPARD Q03181 1/20 0.57
PPARA Q07869 1/20 0.57
POLB P06746 2/20 0.55
CYP19A1 P11511 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
AOC3 Q16853 1/20 0.52
LDHA P00338 1/20 0.52
SIGMAR1 Q99720 1/20 0.50
STAT3 P40763 1/20 0.50
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30074670 1.00 CA2 (0.68) CA2TTRATMKDM4EALDH1A1
SCHEMBL21328330 0.92 TTR (0.71) CA2TTRATMKDM4EALDH1A1
SCHEMBL21328363 0.91 TTR (0.65) CA2TTRATMKDM4EALDH1A1
SCHEMBL21328331 0.91 TTR (0.75) CA2TTRATMKDM4EALDH1A1
SCHEMBL9705942 0.86 TTR (0.58) CA2TTRATMKDM4EALDH1A1
SCHEMBL14244430 0.86 TTR (0.54) CA2TTRATMKDM4EALDH1A1
SCHEMBL9172945 0.86 TTR (0.54) CA2TTRATMKDM4EALDH1A1
SCHEMBL11333719 0.86 CALM1 (0.61) CA2TTRATMKDM4EALDH1A1
SCHEMBL9077595 0.85 TTR (0.57) CA2TTRATMKDM4EALDH1A1
SCHEMBL4976340 0.84 TTR (0.67) CA2TTRALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114249786-A Preparation and application of nucleoside intermediate containing N, N-diacyl structure 上海彩迩文生化科技有限公司 2022-03-29 CN claimed
CN-109406646-B Method for detecting content of genotoxic impurity 1-chloromethyl-3, 4-dimethoxybenzene in ivabradine hydrochloride 安徽美诺华药物化学有限公司 2021-09-28 CN claimed
CN-112538025-A Preparation method of fluorine-containing compound for hydrophobic surface treatment agent 湖北福力德鞋业有限责任公司 2021-03-23 CN claimed
CN-109406646-A The detection method of content of genotoxicity impurity 1- chloromethyl -3,4- dimethoxy benzene in hydrochloric acid Ivabradine 安徽美诺华药物化学有限公司 2019-03-01 CN claimed
CN-109233777-A A kind of oil well solid corrosion inhibitor 赵晴晴 2019-01-18 CN claimed
CN-105384650-B A kind of 3,4 dimethoxy-phenylethylamine production technologies 中国石油化工股份有限公司 2017-11-17 CN claimed
CN-102952141-B The synthetic method of meso-tetra-[4-(3,4-dimethoxybenzyloxycarbonyl base) phenyl] porphyrin EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-12-14 CN claimed
CN-105384650-A Production technology of 3,4-dimethoxy phenethylamine CHINA PETROLEUM & CHEM CORP 2016-03-09 CN claimed
CN-105198810-A 2-benzyl-1-isoquinolone compound as well as synthesis method and application thereof UNIV XI AN JIAOTONG 2015-12-30 CN claimed
CN-102791667-B Method for producing high purity aromatic methyl alcohol, and high purity aromatic methyl alcohol composition having excellent storage stability UBE INDUSTRIES 2014-11-05 CN claimed
US-20120323021-A1 METHOD FOR PRODUCING A HIGH-PURITY AROMATIC METHYL ALCOHOL AND HIGH-PURITY AROMATIC METHYL ALCOHOL COMPOSITION HAVING EXCELLENT PRESERVATION STABILITY UBE INDUSTRIES, LTD. (JP) 2012-12-20 US claimed
CN-101838173-A Method for synthesizing stilbene compound by utilizing Kornblum oxidation reaction HEBEI UNIVERSITY OF SCIENCE & TECHNOLOGY 2010-09-22 CN claimed
US-7488748-B2 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists RANBAXY LABORATORIES LIMITED (IN) 2009-02-10 US claimed
CN-100436416-C Novel donepezil synthesis process SOUTHWEST SYNTHETIC PHARMACEUT (CN) 2008-11-26 CN claimed
US-20060247225-A1 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists RANBAXY LABORATORIES LIMITED (IN) 2006-11-02 US claimed
CN-1733728-A Novel donepezil synthesis process SOUTHWEST SYNTHETIC PHARMACEUT (CN) 2006-02-15 CN claimed
EP-0211271-B1 PROCESS FOR THE PREPARATION OF VERATRYL CYANIDE BASF Aktiengesellschaft (DE) 1988-10-12 EP claimed
US-4661610-A Preparation of veratryl cyanide BASF AKTIENGESELLSCHAFT (DE) 1987-04-28 US claimed
EP-0211271-A1 Process for the preparation of veratryl cyanide BASF Aktiengesellschaft (DE) 1987-02-25 EP claimed
US-4264771-A Alkylation of substituted oxazolinone-(5) compounds BASF AKTIENGESELLSCHAFT (DE) 1981-04-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247225-A1 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists CHRM3, CHRM5, CHRM2 CA2 2159/4885TTR 3915/4885ATM 4123/4885
US-20120323021-A1 METHOD FOR PRODUCING A HIGH-PURITY AROMATIC METHYL ALCOHOL AND HIGH-PURITY AROMATIC METHYL ALCOHOL COMPOSITION HAVING EXCELLENT PRESERVATION STABILITY ALKBH5, ALKBH2, ALKBH3 CA2 4299/4885TTR 1712/4885ATM 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.